| Before intervention | After intervention | p-value* | Changes | p-value* |
---|---|---|---|---|---|
Serum 25(OH)D (ng/mL) | Â | Â | Â | Â | Â |
Intervention | 14.14 ± 5.04 | 20.88 ± 5.76 |  < 0.001 | 6.84 |  < 0.001 |
Control | 17.34 ± 5.68 | 16.46 ± 3.93 | 0.1 | 0.88 |  |
hs-CRP (mg/L) | Â | Â | Â | Â | Â |
Intervention | 1.25 (0.2–4.17) | 1.1 (0.3–3.9) | 0.005 | 0.15 | 0.8 |
Control | 0.9 (0.05–3.2) | 1.1 (0.32–4.52) | 0.041 | 0.02 |  |
WBC (billion cells/L) | Â | Â | Â | Â | Â |
Intervention | 6.56 ± 1.57 | 6.35 ± 1.68 | 0.099 | 0.21 | 0.3 |
Control | 6.64 ± 1.5 | 6.57 ± 1.35 | 0.64 | 0.07 |  |
Neutrophil (percent) | Â | Â | Â | Â | Â |
Intervention | 61.25 ± 6.01 | 55.45 ± 4.89 |  < 0.001 | 5.8 | 0.43 |
Control | 58.38 ± 7.13 | 59.38 ± 4.63 | 0.29 | 1 |  |
Lymphocyte (percent) | Â | Â | Â | Â | Â |
Intervention | 36.92 ± 6.52 | 34.17 ± 5.05 | 0.004 | 2.75 | 0.07 |
Control | 36.18 ± 6.48 | 35.28 ± 4.45 | 0.058 | 0.9 |  |
Platelets (billion/L) | Â | Â | Â | Â | Â |
Intervention | 273.81 ± 36.97 | 216.82 ± 44.23 |  < 0.001 | 56.99 | 0.108 |
Control | 235.10 ± 53.07 | 230.44 ± 54.06 | 0.18 | 4.66 |  |
RDW (percent) | Â | Â | Â | Â | Â |
Intervention | 13.18 ± 1.13 | 11.58 ± 1.47 |  < 0.001 | 1.6 | 0.39 |
Control | 13.32 ± 0.93 | 13.35 ± 1.13 | 0.67 | 0.03 |  |
NLR | Â | Â | Â | Â | Â |
Intervention | 1.73 ± 0.43 | 1.66 ± 0.33 | 0.3 | 0.07 | 0.14 |
Control | 1.7 ± 0.52 | 1.77 ± 0.33 | 0.27 | 0.07 |  |
PLR | Â | Â | Â | Â | Â |
Intervention | 7.66 ± 1.76 | 6.52 ± 1.8 |  < 0.001 | 1.14 | 0.74 |
Control | 6.73 ± 2.08 | 6.79 ± 1.8 | 0.21 | 0.06 |  |
RPR | Â | Â | Â | Â | Â |
Intervention | 0.056 ± 0.01 | 0.049 ± 0.008 |  < 0.001 | 0.07 | 0.101 |
Control | 0.061 ± 0.02 | 0.06 ± 0.017 | 0.8 | 0.01 |  |